据知情人士透露，国会民主党要求制药公司立即披露其与特朗普政府“最惠国”协议的未编辑细节。
Congressional Democrats are demanding pharmaceutical companies immediately disclose the un-redacted details of their “most favored nation” agreements with the Trump administration, according to a source familiar with the effort.
这项要求来自明年国会可能的卫生政策领导人——能源和商务委员会民主党众议员弗兰克·帕洛恩（新泽西州）、筹款委员会民主党众议员理查德·尼尔（马萨诸塞州）、教育和劳动力委员会民主党众议员鲍比·斯科特（弗吉尼亚州）以及参议院财政委员会民主党参议员罗恩·怀登（俄勒冈州）。
The request to drugmakers comes from the potential health policy leaders in Congress next year — Democratic Reps. Frank Pallone Jr. (N.J.) of the Energy and Commerce Committee, Richard Neal (Mass.) of the Ways and Means Committee and Bobby Scott (Va.) of the Education and Workforce Committee and Sen. Ron Wyden (D-Ore.) of the Senate Finance Committee.
这标志着民主党监督力度的显著升级，向制药公司发出信号，即新的民主党多数派将审查其与特朗普政府的交易。
It represents a significant escalation of Democrats’ oversight and signals to pharmaceutical companies the new Democratic majority is going to scrutinize their dealings with the Trump administration.
知情人士表示，如果公司因某些原因无法提供协议细节——例如与白宫可能存在的保密协议——他们被告知在未来两周内与立法者会面，讨论如何履行该请求。
If the companies can’t provide details of the agreements for some reason — such as potential non-disclosure agreements with the White House— they were told to meet with lawmakers in the next two weeks to discuss how they plan to fulfill the request, the source said.
这四位立法者三月曾发信函索要最惠国协议副本，但特朗普政府未予理会。一旦掌权，民主党将有能力要求提供文件、发出传票并就特朗普政府的议程举行听证会。
The same four lawmakers sent a letter in March requesting copies of the most-favored-nation agreements, which the administration ignored. Once in power, Democrats will have the ability to demand documents, issue subpoenas and hold hearings on the Trump administration’s agenda.
民主党一直对特朗普政府的药品定价交易持怀疑态度，特朗普政府官员和公司高管均称这些交易属于机密。立法者想知道，制药公司为降低医疗补助计划药品价格而达成协议，能获得什么回报。
Democrats have been skeptical of the administration’s drug pricing deals, which both Trump administration officials and company executives have said are confidential. Lawmakers want to know what the drug companies are getting in return for their agreements to lower prices for Medicaid.
根据这些协议，制造商承诺不收取高于选定产品最低国际价格的费用。
Under the agreements, manufacturers have pledged not to charge more than the lowest international price for select products.
这些交易一直是特朗普政府医疗议程的关键部分，立法者希望核实特朗普及其他政府官员关于美国民众所获得节省的说法。
The deals have been a key part of the Trump administration’s health agenda, and lawmakers want verify claims Trump and other administration officials have been making about the savings the American people receive.